You searched for Humanized antibody - Page 33 of 45

News and Trends 18 Jun 2020

Belgian mRNA Vaccine for Covid-19 Receives €34M Series B Boost

…have some possible drawbacks. Antibody responses can decline quickly if not backed up by T helper cells, also known as ‘memory’ cells, and it’s possible that a weak antibody response…

June 18, 2020 - 3 minutesmins - By Helen Albert

News and Trends 31 May 2018

UK Biotech Wins Major Grant to Manage Chronic Pain With Antibodies

…a grant of £556K (€633K) from Innovate UK to develop its antibody platform, KnotBody, for therapeutic applications in chronic pain management. Iontas’ antibody approach could provide an alternative to opioids,…

May 31, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 22 Feb 2016

Can this Positive Phase III Immunotherapy End Spinal Fractures due to Osteoporosis?

UCB (Belgium) has a monoclonal antibody candidate (romozumab) which has met its primary endpoints for a phase III Osteoporosis trial, FRAME in partnership with Amgen. The drug showed 75% improvement…

February 22, 2016 - 3 minutesmins - By Denise Neves Gameiro

Best in Biotech 24 Dec 2018

Looking Back on 2018: Our 10 Most Popular Interviews

…Phase II. 10. MorphoSys’ CEO tells us what’s next for Europe’s antibody expert After 25 years, MorphoSys finally got over the line in 2017 with the FDA approval of its…

December 24, 2018 - 8 minutesmins - By Helen Albert

News and Trends 18 Apr 2016

UK Drug Discovery sells Cancer Target to German Pharma

…immunotherapies for cancer with antibody-drug conjugates (ADC) – a strategy to combine the specificity of antibodies to a toxic agent that can be delivered to a cancerous cell. It relies…

April 18, 2016 - 2 minutesmins - By Denise Neves Gameiro

Trevor Baglin XO1 SuperX Virtual Biotech

Interview 19 Jun 2017

Discussing the Virtual Biotech Model with XO1 Co-Founder Trevor Baglin

…A patient presented at my hospital with what’s called a paraprotein, which is sort of a rogue antibody produced by the aging immune system. This antibody targeted exosite 1 of…

June 19, 2017 - 7 minutesmins - By Clara Rodríguez Fernández

Best in Biotech 27 May 2025

Interleukin therapeutics: 9 companies to follow in 2025

…The molecule is fused to a targeting antibody fragment that locks it onto CD8+ T cells and leaves other populations largely untouched. AB248 is currently in a phase 1a/1b clinical…

May 27, 2025 - 12 minutesmins - By Jules Adam

In Depth 11 Dec 2024

Targeting sugar molecules: Can glycobiology lead to a new era for cancer immunotherapy?

…Valora’s immunotherapies look much like a conventional antibody, but with one of the usual Y-like arms replaced with a lectin domain. While the antibody domain provides precise targeting to specific…

December 11, 2024 - 9 minutesmins - By Willow Shah-Neville

tumor cancer immunotherapy alderaan biotech

News and Trends 9 Jan 2020

French Biotech Raises €19M to Hit Phase I with Cancer Immunotherapy

…lead cancer immunotherapy into phase I testing. The candidate is an antibody that depletes T regulatory cells, or Tregs, which help tumors to evade the immune system. Alderaan expects to…

January 9, 2020 - 2 minutesmins - By Jonathan Smith

News and Trends 3 Dec 2015

Meet the Company Fighting Autoimmune Diseases with a Novel Immunotherapy

…at the same time and increase drastically the neutralizing capacity of these antibodies compared to monoclonal antibodies. The kinoids induce a natural antibody response against the targeted protein Fighting lupus…

December 3, 2015 - 4 minutesmins - By Joachim Eeckhout

medical cancer checkpoint inhibitor immunotherapy

News and Trends 29 Apr 2021

BMS’s Cancer Trial Showcases Potential for Checkpoint Inhibitors

…inhibitors against cancer. Last month, the antibody drug relatlimab, developed by Bristol Myers Squibb, increased the progression-free survival of melanoma patients in phase III. These promising results did more than…

April 29, 2021 - 5 minutesmins - By Mark Zipkin

Infographics 19 Jan 2017

Infographic: A History of Approved Therapeutic Antibodies

…With the recent advancements in antibody engineering, we can expect to see an improvement of their half-lives, effector functions or incorporation into antibody-drug conjugates. Since the first antibody hits the…

January 19, 2017 - 1 minutemin - By Marie Godar

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Humanized antibody

Belgian mRNA Vaccine for Covid-19 Receives €34M Series B Boost

UK Biotech Wins Major Grant to Manage Chronic Pain With Antibodies

Can this Positive Phase III Immunotherapy End Spinal Fractures due to Osteoporosis?

Looking Back on 2018: Our 10 Most Popular Interviews

UK Drug Discovery sells Cancer Target to German Pharma

Discussing the Virtual Biotech Model with XO1 Co-Founder Trevor Baglin

Interleukin therapeutics: 9 companies to follow in 2025

Targeting sugar molecules: Can glycobiology lead to a new era for cancer immunotherapy?

French Biotech Raises €19M to Hit Phase I with Cancer Immunotherapy

Meet the Company Fighting Autoimmune Diseases with a Novel Immunotherapy

BMS’s Cancer Trial Showcases Potential for Checkpoint Inhibitors

Infographic: A History of Approved Therapeutic Antibodies

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!